Earnings
SEEL
2.330
-4.90%
-0.120
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
15.66M
--
--
--
--
--
0.00
--
--
--
1.83M
--
17.49M
--
--
--
--
--
--
--
--
0.00
17.49M
--
1.89M
0.00
--
--
--
--
--
1.92M
--
--
--
1.19M
7.43M
7.29M
--
--
--
200.00K
7.49M
14.92M
54.00K
77.68M
-75.16M
--
--
--
2.57M
2.57M
17.49M
FY 2019-12-31
10.26M
--
--
--
--
--
0.00
--
--
--
835.00K
0.00
11.10M
--
--
--
--
--
--
--
--
0.00
11.10M
--
796.00K
0.00
--
--
--
--
--
1.92M
--
--
--
8.06M
10.78M
0.00
--
--
--
325.00K
325.00K
11.10M
27.00K
56.03M
-56.06M
--
--
--
-7000.00
-7000.00
11.10M
FY 2018-12-31
42.00K
--
--
--
--
--
0.00
--
--
--
9000.00
140.00K
191.00K
38.00K
--
--
--
--
--
--
0.00
0.00
191.00K
--
2.22M
2.44M
--
--
--
--
--
235.00K
--
--
--
0.00
4.90M
0.00
--
--
--
0.00
0.00
4.90M
3000.00
97.00K
-4.81M
--
--
--
-4.71M
-4.71M
191.00K
FY 2017-12-31
6.33M
--
--
--
--
--
0.00
--
--
--
261.00K
0.00
6.59M
79.00K
--
--
--
--
--
--
35.00K
114.00K
6.71M
--
58.00K
0.00
--
--
--
--
--
1.51M
--
--
--
12.00K
1.58M
0.00
--
--
--
752.00K
752.00K
2.33M
15.00K
320.34M
-315.99M
--
--
--
4.37M
4.37M
6.71M
FY 2016-12-31
2.09M
--
--
530.00K
--
--
0.00
--
764.00K
--
177.00K
1.37M
3.63M
164.00K
--
--
--
--
--
--
902.00K
1.07M
4.70M
--
763.00K
6.65M
--
--
--
--
--
1.95M
--
--
--
1.93M
11.29M
0.00
--
--
--
922.00K
922.00K
12.22M
8000.00
308.78M
-316.31M
--
--
--
-7.52M
-7.52M
4.70M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out SEEL latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Seelos Therapeutics Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.